BioNumerik purchases Cray supercomputer



The purchase doubles BioNumerik's existing computing capacity, memory and bandwidth, allowing the company to tackle even larger quantum chemistry problems, which are critical for creating new cancer-fighting drugs. BioNumerik runs complex GAUSSIAN, AMBER and its own proprietary applications on its Cray supercomputers and then tests the systems predictions in the lab. By integrating the latest lab technologies with high-performance computing, BioNumerik hopes to shorten development times leading to more cost-effective drugs.

More than 100 Cray SV1 systems have been installed since they were introduced in August 1999. Installation of the SV1 supercomputer at BioNumerik's San Antonio, Texas facility was completed in December 2000.